CB Rank (Person) 517,337

Craig Kussman brings to XIFIN over 25 years’ experience in financial, strategic, and operational management of both healthcare and technology organizations.

Prior to joining XIFIN, Mr. Kussman was CFO and co-CEO of Breach Security, a provider of web application firewall products, where he played a vital role in its sale to Trustwave.

Previously, Mr. Kussman was CFO at Ascenta Therapeutics, where he led a $52 million financing round. Before Ascenta Therapeutics, Mr. Kussman was CFO and chief administrative officer at Discovery Partners International, Inc., where he shepherded the merger of Discovery Partners with Infinity Pharmaceuticals, Inc.

Mr. Kussman has also held key roles at SYNAVANT Inc., IMS HEALTH, Cognizant Corporation and The Dun & Bradstreet Corporation.

Mr. Kussman has a B.A. in economics and mathematics from Pomona College and an M.B.A. from the Wharton School of Business.

Number of Current Jobs 1
Number of Past Jobs 8
Craig Kussman is the Chief Financial Officer at Organovo Holdings. Additionally, Craig Kussman has had 8 past jobs including CFO at XIFIN.
Organization Name  
Title At Company  
Start Date  
End Date  
XIFIN
CFOJul 2010Oct 2014
Alphaeon
Chief Financial Officer
Infinity Pharmaceuticals
Team Member
IMS Health
Key Roles
Breach Security
CFO and Co-CEO
Discovery Partners International
CFO and Chief Administrative Officer
Ascenta Therapeutics
CFO
Cognizant
Key Roles
Number of News Articles 1
NewsAug 2, 2016
SoCal - Tech — Organovo Names CFO